These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 16388773

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Combination pharmacotherapy therapy in the management of atherogenic dyslipidemia].
    Kłosiewicz-Latoszek L, Cybulska B.
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II76-80. PubMed ID: 19813341
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
    MMW Fortschr Med; 2005 Nov 10; 147(45):54. PubMed ID: 16320655
    [No Abstract] [Full Text] [Related]

  • 8. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
    Landesman KA, Stozek M, Freeman NJ.
    Conn Med; 1999 Aug 10; 63(8):455-7. PubMed ID: 10500341
    [Abstract] [Full Text] [Related]

  • 9. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R, Goldberg AC.
    Endocrinol Metab Clin North Am; 2009 Mar 10; 38(1):79-97. PubMed ID: 19217513
    [Abstract] [Full Text] [Related]

  • 10. [How sure is the combined lipid lowering?].
    Schäfer J.
    MMW Fortschr Med; 2005 Jan 13; 147(1-2):56. PubMed ID: 15704576
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily].
    MMW Fortschr Med; 2005 Nov 10; 147(45):55. PubMed ID: 16320656
    [No Abstract] [Full Text] [Related]

  • 13. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM, Farmer JA.
    Nat Clin Pract Cardiovasc Med; 2006 Dec 10; 3(12):664-72. PubMed ID: 17122799
    [Abstract] [Full Text] [Related]

  • 14. Treatment of hyperlipidemia in elderly persons with exercise training, nonpharmacologic therapy, and drug combinations.
    Lavie CJ.
    Am J Geriatr Cardiol; 2004 Dec 10; 13(3 Suppl 1):29-33. PubMed ID: 15133427
    [Abstract] [Full Text] [Related]

  • 15. [When should an association of lipid-lowering drugs be proposed in a patient failing to reach therapeutic targets under monotherapy? Guidelines of the New French Society of Atherosclerosis].
    Farnier M, Bonnet F, Bruckert E, Ferrières J, Paillard F, New French Society of Atherosclerosis.
    Arch Mal Coeur Vaiss; 2007 Dec 10; 100(6-7):569-81. PubMed ID: 17893640
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. On the road to better dyslipidemia outcomes.
    Hughes S.
    Nurse Pract; 2009 Feb 10; 34(2):14-21; quiz 22. PubMed ID: 19155874
    [No Abstract] [Full Text] [Related]

  • 18. [New indications and therapeutic objectives for dyslipidemia].
    Maiques Galán A.
    Aten Primaria; 2006 Nov 30; 38(9):473-5. PubMed ID: 17194348
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.